Clinical trial
Postpartum Heparin Against Venous Thromboembolism: a Pilot Randomized Controlled Trial
NCT05878899 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Postpartum Heparin Against Venous Thromboembolism: a Pilot Randomized Controlled Trial
- Lead sponsor
- University Hospital, Geneva
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 3, 2022
- Completion date
- March 13, 2023
- Enrollment
- 77 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.